Suicidal behavior in @entity162 : what is the influence of XXXX comorbidities?

@entity1 @entity1314 @entity162 @entity4225 @entity4697 @entity146 @entity988 @entity148 @entity2270
OBJECTIVE: To assess the frequency of some @entity146 comorbidities found to be associated with suicidal behavior in previous studies and to evaluate their influence on suicidal behavior in a sample of @entity1 with @entity162 . METHOD: We assessed 239 bipolar @entity1 from January 2005 to January 2007. @entity2270 diagnosis was performed according to the DSM-IV using a structured interview (the Mini-International Neuropsychiatric Interview-Plus), and @entity4225 was assessed using the Structured Clinical Interview for DSM-IV @entity1314 . Lifetime suicide history was assessed using a semistructured interview in addition to a review of medical records. RESULTS: There were 99 @entity1 (41.4%) with a history of previous suicide attempts. The @entity146 comorbidities associated with suicidal behavior were @entity4225 (chi(2) = 36.008, p = .0001), @entity4697 (chi(2) = 5.537, p = .019), @entity988 (chi(2) = 12.820, p = .001), other drug addictions (chi(2) = 10.055, p = .02), generalized @entity148 (chi(2) = 10.216, p = .001), and smoking (chi(2) = 9.070, p = .003). However, when logistic regression analyses were used, only the diagnosis of @entity1314 remained significant (Wald chi(2) = 19.13, p = .0001). When analyzing the subtypes of suicide attempts, we found that @entity4225 and @entity988 were associated with violent suicide attempts. CONCLUSION: A diagnosis of @entity4225 or @entity988 (only for violent sub-type of suicidal behavior) was the only comorbidity independently associated with suicide in @entity1 with @entity162 . For suicide prevention, screening to identify @entity1 at high risk for suicidal behavior should be performed routinely in @entity1 with @entity162 .
